BioRender Template
Radiotherapy-Resistant Breast Cancer Patients: Screening and Therapeutic Approach
Use This Template – Free
No credit card required to sign up.
This template is fully editable in BioRender
- Swap in different text, shapes, & icons
- Recolor and rearrange every icon, line, & label
- Export or share for any use case
Join 4M+ scientists already making publication-ready figures
Description:
This template was adapted from the original submission. Edits were made to enhance scientific accuracy, optimal usability and/or to meet industry-leading design standards for science communication.
About 80% of breast cancer (BCa) patients benefit from radiotherapy (RT). However, advanced invasive tumors can develop resistance. The majority of BCa patients receive RT without considering disease biology. Consequently, radioresistant BCa patients also receive RT even though they will not respond. Therefore, there is an urgent need to unveil the mechanisms underlying BCa radioresistance to allow screening of RT-resistant BCa patients and improve the clinical management towards therapy response.
Updated
August 2026
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Not quite the right template? Discover more.
Search thousands of templates across 30+ life-science fields.
Popular topics:
Cell
Cancer
Drug Delivery
Mechanism of Action
Pathway
Try a synonym, or sign up to suggest a template from the app.
Newest templates
BioRender Template FAQs
This template was adapted from the original submission. Edits were made to enhance scientific accuracy, optimal usability and/or to meet industry-leading design standards for science communication.
About 80% of breast cancer (BCa) patients benefit from radiotherapy (RT). However, advanced invasive tumors can develop resistance. The majority of BCa patients receive RT without considering disease biology. Consequently, radioresistant BCa patients also receive RT even though they will not respond. Therefore, there is an urgent need to unveil the mechanisms underlying BCa radioresistance to allow screening of RT-resistant BCa patients and improve the clinical management towards therapy response.